SynAct Pharma AB (FRA:8F8)
1.884
-0.156 (-7.65%)
At close: Jan 5, 2026
94.83% (1Y)
| Market Cap | 110.47M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.61M |
| Shares Out | n/a |
| EPS (ttm) | -0.20 |
| PE Ratio | n/a |
| Forward PE | 82.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 51 |
| Open | 1.976 |
| Previous Close | 2.040 |
| Day's Range | 1.884 - 2.000 |
| 52-Week Range | 0.743 - 2.320 |
| Beta | n/a |
| RSI | 56.28 |
| Earnings Date | Feb 18, 2026 |